ALS Stole His Voice, AI Helped Him Find It Again | NPR

The loss of a voice – a gradual silencing – is a particularly cruel aspect of amyotrophic lateral sclerosis (ALS). For actor Eric Dane, known for his role as Dr. Mark Sloan on Grey’s Anatomy, that reality became devastatingly clear as the disease progressed. He died last month at the age of 53, just months after his diagnosis in April of 2025. His widow, Rebecca Gayheart Dane, has spoken movingly about the experience, and a recent project undertaken before his death offers a poignant example of how technology is being used to preserve what is lost to this relentless disease.

ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. These nerve cells control voluntary muscle movement, and as they die, individuals experience increasing difficulty with physical functions like walking, speaking, and eventually, breathing. The disease currently has no cure, and treatment focuses on managing symptoms and improving quality of life.

Preserving a Voice, Preserving a Legacy

As Eric Dane’s ability to speak diminished, Rebecca Gayheart Dane sought a way to preserve his voice for their daughters, Billie and Georgia. “He was witty, acerbic, full of humor, and he always had a great story,” she told NPR. “So, as speaking became harder for him, I watched and witnessed some of his joy fade, and it was really hard and very heartbreaking.” That search led them to ElevenLabs, a company specializing in artificial intelligence voice technology. ElevenLabs has been developing tools to recreate voices from audio samples, offering a potential lifeline for individuals losing their ability to communicate.

The process involved recording Dane’s voice while he was still able to speak, capturing the nuances of his tone, inflection, and cadence. Using this data, ElevenLabs created a synthetic version of his voice. The result, according to Gayheart Dane, was profoundly emotional. “He was waiting anxiously to hear it, and when we got it from ElevenLabs it was a really big moment. It was a powerful moment. We played it, and Eric became visibly emotional,” she shared. “And when I heard it, I cried. I think everyone in the room did.” Their daughters’ reaction was equally powerful, recognizing the recreated voice as undeniably their father’s.

The Promise and Complexity of Voice Restoration

This project highlights a growing area of interest within the medical and technological communities: voice restoration for individuals with speech impairments. While the technology is still relatively new, it holds significant promise for those affected by conditions like ALS, stroke, or head and neck cancer. However, it also raises complex ethical and emotional considerations. The ability to recreate a voice after someone has passed away, for example, prompts questions about identity, memory, and the nature of communication.

ElevenLabs’ Impact Program specifically focuses on providing this technology to individuals facing voice loss. The program aims to offer a voice preservation solution, allowing people to continue communicating and connecting with loved ones even as their physical abilities decline. The technology isn’t simply about replicating speech; it’s about preserving a fundamental aspect of a person’s identity.

Beyond the Technology: The Role of Caregiving

Gayheart Dane’s experience also underscores the immense challenges faced by caregivers of individuals with ALS. Watching a loved one lose their ability to communicate is profoundly difficult, and the emotional toll can be significant. She spoke candidly about witnessing the fading of her husband’s joy as his voice disappeared. Caregiving often involves navigating complex medical systems, providing physical and emotional support, and adapting to constantly changing needs. Resources for caregivers, including support groups and respite care, are crucial in helping them cope with the demands of this role.

ALS Awareness and Ongoing Research

Eric Dane’s diagnosis and subsequent death have brought renewed attention to ALS and the urgent need for research. While there is currently no cure, ongoing studies are exploring potential treatments to gradual the progression of the disease and improve the quality of life for those affected. These include investigations into gene therapies, stem cell therapies, and new drug targets. Increased funding for ALS research is essential to accelerate these efforts.

The ALS Association, for example, is actively involved in funding research and providing support services to individuals and families affected by the disease. Their website (https://www.als.org/) offers comprehensive information about ALS, including symptoms, diagnosis, treatment options, and resources for caregivers.

What Comes Next: Advancing Voice Technology and ALS Care

The use of AI-powered voice restoration technology is likely to grow more widespread as the technology improves and becomes more accessible. Further research is needed to refine the algorithms and ensure that the recreated voices are as natural and authentic as possible. Ongoing dialogue is needed to address the ethical considerations surrounding this technology and to establish guidelines for its responsible use.

For those living with ALS, continued advancements in care and support services are paramount. This includes access to multidisciplinary clinics, specialized equipment, and emotional support for both patients and their families. Raising awareness about ALS and advocating for increased research funding remain critical steps in the fight against this devastating disease.